ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure

Clinical trial NCT00610051 · NOT_YET_RECRUITING

Trial details

NCT number: NCT00610051
Sponsor: Biopeutics Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

End Stage Cardiac Failure HFrEF - Heart Failure With Reduced Ejection Fraction NYHF Class III-IV

Start date: 2026-10-01
Primary completion: 2029-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.